supporting accumulating data showing that antibodies or other small molecules that inhibit HSP90 can be used as anti-cancer agents [24] This prompted us to explore the anti-metastatic activity of mAb 4C5 with respect to MDAMB453 breast cancer cells. Here, HSP90AA1 is linked to breast carcinoma.